Trial Profile
Botulinum Toxin Serotype A randomized double-blind, placebo controlled multicentre study for degenerative coxarthrosis. Studio randomizzato, multicentrico, in doppio cieco controllato con placebo sull'impiego di tossina botulinica di tipo A, nel trattamento della coxartrosi degenerativa.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 01 Apr 2016
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Osteoarthritis
- Focus Therapeutic Use
- Acronyms BOLD
- 01 Apr 2016 Status changed from recruiting to completed as reported by European Clinical Trials Database record.
- 20 Jun 2013 New trial record